{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T23:14:25Z","timestamp":1740179665697,"version":"3.37.3"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T00:00:00Z","timestamp":1592784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Geriatr Med"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s41999-020-00349-4","type":"journal-article","created":{"date-parts":[[2020,6,22]],"date-time":"2020-06-22T19:03:51Z","timestamp":1592852631000},"page":"1017-1026","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The association between antidepressants use and development of cognitive impairment among older women diagnosed with breast cancer"],"prefix":"10.1007","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8167-6931","authenticated-orcid":false,"given":"Yasser","family":"Alatawi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard A.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiahung","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingjing","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishnu","family":"Suppiramaniam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guanqun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,22]]},"reference":[{"key":"349_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-018-05078-8","author":"SS Coughlin","year":"2019","unstructured":"Coughlin SS, Paxton RJ, Moore N, Stewart JL, Anglin J (2019) Survivorship issues in older breast cancer survivors. Breast Cancer Res Treat. https:\/\/doi.org\/10.1007\/s10549-018-05078-8","journal-title":"Breast Cancer Res Treat"},{"key":"349_CR2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-clinpsy-050817-084903","author":"TA Ahles","year":"2018","unstructured":"Ahles TA, Root JC (2018) Cognitive effects of cancer and cancer treatments. Annu Rev Clin Psychol. https:\/\/doi.org\/10.1146\/annurev-clinpsy-050817-084903","journal-title":"Annu Rev Clin Psychol"},{"key":"349_CR3","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdm500","author":"J Vardy","year":"2008","unstructured":"Vardy J, Wefel JS, Ahles T, Tannock IF, Schagen SB (2008) Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol. https:\/\/doi.org\/10.1093\/annonc\/mdm500","journal-title":"Ann Oncol"},{"key":"349_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-007-9686-5","author":"TA Ahles","year":"2008","unstructured":"Ahles TA, Saykin AJ, McDonald BC, Furstenberg CT, Cole BF, Hanscom BS et al (2008) Cognitive function in breast cancer patients prior to adjuvant treatment. Breast Cancer Res Treat. https:\/\/doi.org\/10.1007\/s10549-007-9686-5","journal-title":"Breast Cancer Res Treat"},{"key":"349_CR5","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.2050","author":"JS Mandelblatt","year":"2014","unstructured":"Mandelblatt JS, Stern RA, Luta G, McGuckin M, Clapp JD, Hurria A et al (2014) Cognitive impairment in older patients with breast cancer before systemic therapy: is there an interaction between cancer and comorbidity? J Clin Oncol. https:\/\/doi.org\/10.1200\/JCO.2013.54.2050","journal-title":"J Clin Oncol"},{"key":"349_CR6","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31828726f5","author":"LE Hebert","year":"2013","unstructured":"Hebert LE, Weuve J, Scherr PA, Evans DA (2013) Alzheimer disease in the United States (2010\u20132050) estimated using the 2010 census. Neurology. https:\/\/doi.org\/10.1212\/WNL.0b013e31828726f5","journal-title":"Neurology"},{"key":"349_CR7","doi-asserted-by":"publisher","DOI":"10.7326\/M15-0381","author":"AS Kelley","year":"2015","unstructured":"Kelley AS, McGarry K, Gorges R, Skinner JS (2015) The burden of health care costs for patients with dementia in the last 5 years of life. Ann Intern Med. https:\/\/doi.org\/10.7326\/M15-0381","journal-title":"Ann Intern Med"},{"key":"349_CR8","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2011.154","author":"W Katon","year":"2012","unstructured":"Katon W, Lyles CR, Parker MM, Karter AJ, Huang ES, Whitmer RA (2012) Association of depression with increased risk of dementia in patients with type 2 diabetes: the Diabetes and aging study. Arch Gen Psychiatry. https:\/\/doi.org\/10.1001\/archgenpsychiatry.2011.154","journal-title":"Arch Gen Psychiatry"},{"key":"349_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s41999-019-00185-1","author":"MG Borda","year":"2019","unstructured":"Borda MG, Santacruz JM, Aarsland D, Camargo-Casas S, Cano-Gutierrez CA, Suarez-Monsalve S et al (2019) Association of depressive symptoms and subjective memory complaints with the incidence of cognitive impairment in older adults with high blood pressure. Eur Geriatr Med. https:\/\/doi.org\/10.1007\/s41999-019-00185-1","journal-title":"Eur Geriatr Med"},{"key":"349_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/gps.5301","author":"Y Yuan","year":"2020","unstructured":"Yuan Y, Min HS, Lapane KL, Rothschild AJ, Ulbricht CM (2020) Depression symptoms and cognitive impairment in older nursing home residents in the USA: a latent class analysis. Int J Geriatr Psychiatry. https:\/\/doi.org\/10.1002\/gps.5301","journal-title":"Int J Geriatr Psychiatry"},{"key":"349_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s11065-020-09436-6","author":"VM Dotson","year":"2020","unstructured":"Dotson VM, McClintock SM, Verhaeghen P, Kim JU, Draheim AA, Syzmkowicz SM et al (2020) Depression and cognitive control across the lifespan: a systematic review and meta-analysis. Neuropsychol Rev. https:\/\/doi.org\/10.1007\/s11065-020-09436-6","journal-title":"Neuropsychol Rev"},{"key":"349_CR12","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2017.0660","author":"A Singh-Manoux","year":"2017","unstructured":"Singh-Manoux A, Dugravot A, Fournier A, Abell J, Ebmeier K, Kivim\u00e4ki M et al (2017) Trajectories of depressive symptoms before diagnosis of dementia: a 28-year follow-up study. JAMA Psychiatry. https:\/\/doi.org\/10.1001\/jamapsychiatry.2017.0660","journal-title":"JAMA Psychiatry"},{"key":"349_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/pon.3409","author":"AMH Krebber","year":"2014","unstructured":"Krebber AMH, Buffart LM, Kleijn G, Riepma IC, de Bree R, Leemans CR et al (2014) Prevalence of depression in cancer patients: a meta-analysis of diagnostic interviews and self-report instruments. Psychooncology. https:\/\/doi.org\/10.1002\/pon.3409","journal-title":"Psychooncology"},{"key":"349_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/pon.3606","author":"MJ Fisch","year":"2015","unstructured":"Fisch MJ, Zhao F, Manola J, Miller AH, Pirl WF, Wagner LI (2015) Patterns and predictors of antidepressant use in ambulatory cancer patients with common solid tumors. Psychooncology. https:\/\/doi.org\/10.1002\/pon.3606","journal-title":"Psychooncology"},{"key":"349_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-019-03043-5","author":"S-C Park","year":"2019","unstructured":"Park S-C (2019) Neurogenesis and antidepressant action. Cell Tissue Res. https:\/\/doi.org\/10.1007\/s00441-019-03043-5","journal-title":"Cell Tissue Res"},{"key":"349_CR16","doi-asserted-by":"publisher","DOI":"10.2174\/138161206777698909","author":"JA Schmitt","year":"2006","unstructured":"Schmitt JA, Wingen M, Ramaekers JG, Evers EA, Riedel WJ (2006) Serotonin and human cognitive performance. Curr Pharm Des. https:\/\/doi.org\/10.2174\/138161206777698909","journal-title":"Curr Pharm Des"},{"key":"349_CR17","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1107411108","author":"JR Cirrito","year":"2011","unstructured":"Cirrito JR, Disabato BM, Restivo JL, Verges DK, Goebel WD, Sathyan A et al (2011) Serotonin signaling is associated with lower amyloid-beta levels and plaques in transgenic mice and humans. Proc Natl Acad Sci. https:\/\/doi.org\/10.1073\/pnas.1107411108","journal-title":"Proc Natl Acad Sci"},{"key":"349_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2011.02.026","author":"F Shen","year":"2011","unstructured":"Shen F, Smith JA, Chang R, Bourdet DL, Tsuruda PR, Obedencio GP et al (2011) 5-HT(4) receptor agonist mediated enhancement of cognitive function in vivo and amyloid precursor protein processing in vitro: a pharmacodynamic and pharmacokinetic assessment. Neuropharmacology. https:\/\/doi.org\/10.1016\/j.neuropharm.2011.02.026","journal-title":"Neuropharmacology"},{"key":"349_CR19","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0b013e31802e0002","author":"A Mowla","year":"2007","unstructured":"Mowla A, Mosavinasab M, Pani A (2007) Does fluoxetine have any effect on the cognition of patients with mild cognitive impairment? A double-blind, placebo-controlled, clinical trial. J Clin Psychopharmacol. https:\/\/doi.org\/10.1097\/JCP.0b013e31802e0002","journal-title":"J Clin Psychopharmacol"},{"key":"349_CR20","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1377041","author":"N Mokhber","year":"2014","unstructured":"Mokhber N, Abdollahian E, Soltanifar A, Samadi R, Saghebi A, Haghighi MB et al (2014) Comparison of sertraline, venlafaxine and desipramine effects on depression, cognition and the daily living activities in Alzheimer patients. Pharmacopsychiatry. https:\/\/doi.org\/10.1055\/s-0034-1377041","journal-title":"Pharmacopsychiatry"},{"key":"349_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/gps.4384","author":"YM Choe","year":"2016","unstructured":"Choe YM, Kim KW, Jhoo JH, Ryu SH, Seo EH, Sohn BK et al (2016) Multicenter, randomized, placebo-controlled, double-blind clinical trial of escitalopram on the progression-delaying effects in Alzheimer's disease. Int J Geriatr Psychiatry. https:\/\/doi.org\/10.1002\/gps.4384","journal-title":"Int J Geriatr Psychiatry"},{"key":"349_CR22","doi-asserted-by":"publisher","DOI":"10.1097\/JGP.0b013e31826ce4c5","author":"CA Munro","year":"2012","unstructured":"Munro CA, Longmire CF, Drye LT, Martin BK, Frangakis CE, Meinert CL et al (2012) Cognitive outcomes after sertaline treatment in patients with depression of Alzheimer disease. Am J Geriatr Psychiatry. https:\/\/doi.org\/10.1097\/JGP.0b013e31826ce4c5","journal-title":"Am J Geriatr Psychiatry"},{"key":"349_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60830-1","author":"S Banerjee","year":"2011","unstructured":"Banerjee S, Hellier J, Dewey M, Romeo R, Ballard C, Baldwin R et al (2011) Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. Lancet. https:\/\/doi.org\/10.1016\/S0140-6736(11)60830-1","journal-title":"Lancet"},{"key":"349_CR24","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.93","author":"AP Porsteinsson","year":"2014","unstructured":"Porsteinsson AP, Drye LT, Pollock BG, Devanand DP, Frangakis C, Ismail Z et al (2014) Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial. JAMA. https:\/\/doi.org\/10.1001\/jama.2014.93","journal-title":"JAMA"},{"key":"349_CR25","doi-asserted-by":"publisher","DOI":"10.1097\/YIC.0b013e32834ace0f","author":"LV Kessing","year":"2011","unstructured":"Kessing LV, Forman JL, Andersen PK (2011) Do continued antidepressants protect against dementia in patients with severe depressive disorder? Int Clin Psychopharmacol. https:\/\/doi.org\/10.1097\/YIC.0b013e32834ace0f","journal-title":"Int Clin Psychopharmacol"},{"key":"349_CR26","doi-asserted-by":"publisher","DOI":"10.1097\/JGP.0b013e318181f9b1","author":"G Ravaglia","year":"2008","unstructured":"Ravaglia G, Forti P, Lucicesare A, Rietti E, Pisacane N, Mariani E et al (2008) Prevalent depressive symptoms as a risk factor for conversion to mild cognitive impairment in an elderly Italian cohort. Am J Geriatr Psychiatry. https:\/\/doi.org\/10.1097\/JGP.0b013e318181f9b1","journal-title":"Am J Geriatr Psychiatry"},{"key":"349_CR27","doi-asserted-by":"publisher","DOI":"10.1017\/S1041610211002778","author":"JS Goveas","year":"2012","unstructured":"Goveas JS, Hogan PE, Kotchen JM, Smoller JW, Denburg NL, Manson JE et al (2012) Depressive symptoms, antidepressant use, and future cognitive health in postmenopausal women: the Women's Health Initiative Memory Study. Int Psychogeriatr. https:\/\/doi.org\/10.1017\/S1041610211002778","journal-title":"Int Psychogeriatr"},{"key":"349_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2015.01.007","author":"JS Saczynski","year":"2015","unstructured":"Saczynski JS, Rosen AB, McCammon RJ, Zivin K, Andrade SE, Langa KM et al (2015) Antidepressant use and cognitive decline: the health and retirement study. Am J Med. https:\/\/doi.org\/10.1016\/j.amjmed.2015.01.007","journal-title":"Am J Med"},{"key":"349_CR29","doi-asserted-by":"publisher","DOI":"10.1097\/01.MLR.0000020942.47004.03","author":"JL Warren","year":"2002","unstructured":"Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF (2002) Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care. https:\/\/doi.org\/10.1097\/01.MLR.0000020942.47004.03","journal-title":"Med Care"},{"key":"349_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/s0895-4356(00)00256-0","author":"CN Klabunde","year":"2000","unstructured":"Klabunde CN, Potosky AL, Legler JM, Warren JL (2000) Development of a comorbidity index using physician claims data. J Clin Epidemiol. https:\/\/doi.org\/10.1016\/s0895-4356(00)00256-0","journal-title":"J Clin Epidemiol"},{"key":"349_CR31","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.8272","author":"JH Silber","year":"2013","unstructured":"Silber JH, Rosenbaum PR, Clark AS, Giantonio BJ, Ross RN, Teng Y et al (2013) Characteristics associated with differences in survival among black and white women with breast cancer. JAMA. https:\/\/doi.org\/10.1001\/jama.2013.8272","journal-title":"JAMA"},{"key":"349_CR32","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2008.01848.x","author":"JE Heck","year":"2008","unstructured":"Heck JE, Albert SM, Franco R, Gorin SS (2008) Patterns of dementia diagnosis in surveillance, epidemiology, and end results breast cancer survivors who use chemotherapy. J Am Geriatr Soc. https:\/\/doi.org\/10.1111\/j.1532-5415.2008.01848.x","journal-title":"J Am Geriatr Soc"},{"key":"349_CR33","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.12.1949","author":"MA Butters","year":"2000","unstructured":"Butters MA, Becker JT, Nebes RD, Zmuda MD, Mulsant BH, Pollock BG et al (2000) Changes in cognitive functioning following treatment of late-life depression. Am J Psychiatry. https:\/\/doi.org\/10.1176\/appi.ajp.157.12.1949","journal-title":"Am J Psychiatry"},{"key":"349_CR34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1819.2006.01564.x","author":"L Mandelli","year":"2006","unstructured":"Mandelli L, Serretti A, Colombo C, Florita M, Santoro A, Rossini D et al (2006) Improvement of cognitive functioning in mood disorder patients with depressive symptomatic recovery during treatment: an exploratory analysis. Psychiatry Clin Neurosci. https:\/\/doi.org\/10.1111\/j.1440-1819.2006.01564.x","journal-title":"Psychiatry Clin Neurosci"},{"key":"349_CR35","doi-asserted-by":"publisher","DOI":"10.1097\/jgp.0b013e3181b4bf4a","author":"ME Culang","year":"2009","unstructured":"Culang ME, Sneed JR, Keilp JG, Rutherford BR, Pelton GH, Devanand DP et al (2009) Change in cognitive functioning following acute antidepressant treatment in late-life depression. Am J Geriatr Psychiatry. https:\/\/doi.org\/10.1097\/jgp.0b013e3181b4bf4a","journal-title":"Am J Geriatr Psychiatry"},{"key":"349_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s11065-018-9369-5","author":"CE Prado","year":"2018","unstructured":"Prado CE, Watt S, Crowe SF (2018) A meta-analysis of the effects of antidepressants on cognitive functioning in depressed and non-depressed samples. Neuropsychol Rev. https:\/\/doi.org\/10.1007\/s11065-018-9369-5","journal-title":"Neuropsychol Rev"},{"key":"349_CR37","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2010.184","author":"CF Reynolds 3rd","year":"2011","unstructured":"Reynolds CF 3rd, Butters MA, Lopez O, Pollock BG, Dew MA, Mulsant BH et al (2011) Maintenance treatment of depression in old age: a randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of donepezil combined with antidepressant pharmacotherapy. Arch Gen Psychiatry. https:\/\/doi.org\/10.1001\/archgenpsychiatry.2010.184","journal-title":"Arch Gen Psychiatry"},{"key":"349_CR38","doi-asserted-by":"publisher","DOI":"10.1097\/WAD.0000000000000103","author":"C Wang","year":"2016","unstructured":"Wang C, Gao S, Hendrie HC, Kesterson J, Campbell NL, Shekhar A et al (2016) Antidepressant use in the elderly is associated with an increased risk of dementia. Alzheimer Dis Assoc Disord. https:\/\/doi.org\/10.1097\/WAD.0000000000000103","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"349_CR39","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.24.2959","author":"MA Espeland","year":"2004","unstructured":"Espeland MA, Rapp SR, Shumaker SA, Brunner R, Manson JE, Sherwin BB et al (2004) Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA. https:\/\/doi.org\/10.1001\/jama.291.24.2959","journal-title":"JAMA"},{"key":"349_CR40","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/glw156","author":"MA Espeland","year":"2017","unstructured":"Espeland MA, Rapp SR, Manson JE, Goveas JS, Shumaker SA, Hayden KM et al (2017) Long-term effects on cognitive trajectories of postmenopausal hormone therapy in two age groups. J Gerontol A Biol Sci Med Sci. https:\/\/doi.org\/10.1093\/gerona\/glw156","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"349_CR41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2011.03491.x","author":"C Fox","year":"2011","unstructured":"Fox C, Richardson K, Maidment ID, Savva GM, Matthews FE, Smithard D et al (2011) Anticholinergic medication use and cognitive impairment in the older population: the medical research council cognitive function and ageing study. J Am Geriatr Soc. https:\/\/doi.org\/10.1111\/j.1532-5415.2011.03491.x","journal-title":"J Am Geriatr Soc"},{"key":"349_CR42","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afr102","author":"C Fox","year":"2011","unstructured":"Fox C, Livingston G, Maidment ID, Coulton S, Smithard DG, Boustani M et al (2011) The impact of anticholinergic burden in Alzheimer's dementia\u2014the LASER-AD study. Age Ageing. https:\/\/doi.org\/10.1093\/ageing\/afr102","journal-title":"Age Ageing"},{"key":"349_CR43","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181e7f2ab","author":"NL Campbell","year":"2010","unstructured":"Campbell NL, Boustani MA, Lane KA, Gao S, Hendrie H, Khan BA et al (2010) Use of anticholinergics and the risk of cognitive impairment in an African American population. Neurology. https:\/\/doi.org\/10.1212\/WNL.0b013e3181e7f2ab","journal-title":"Neurology"},{"key":"349_CR44","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2106","author":"NL Campbell","year":"2018","unstructured":"Campbell NL, Lane KA, Gao S, Boustani MA, Unverzagt F (2018) Anticholinergics influence transition from normal cognition to mild cognitive impairment in older adults in primary care. Pharmacotherapy. https:\/\/doi.org\/10.1002\/phar.2106","journal-title":"Pharmacotherapy"},{"key":"349_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2013.02.024","author":"K Mlyniec","year":"2013","unstructured":"Mlyniec K, Nowak G (2013) GPR39 up-regulation after selective antidepressants. Neurochem Int. https:\/\/doi.org\/10.1016\/j.neuint.2013.02.024","journal-title":"Neurochem Int"},{"key":"349_CR46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033552","author":"TJ Craddock","year":"2012","unstructured":"Craddock TJ, Tuszynski JA, Chopra D, Casey N, Goldstein LE, Hameroff SR et al (2012) The zinc dyshomeostasis hypothesis of Alzheimer's disease. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0033552","journal-title":"PLoS ONE"},{"key":"349_CR47","doi-asserted-by":"publisher","DOI":"10.1385\/bter:75:1-3:79","author":"LL Rulon","year":"2000","unstructured":"Rulon LL, Robertson JD, Lovell MA, Deibel MA, Ehmann WD, Markesber WR (2000) Serum zinc levels and Alzheimer's disease. Biol Trace Elem Res. https:\/\/doi.org\/10.1385\/bter:75:1-3:79","journal-title":"Biol Trace Elem Res"}],"container-title":["European Geriatric Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41999-020-00349-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s41999-020-00349-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41999-020-00349-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,21]],"date-time":"2021-06-21T23:15:39Z","timestamp":1624317339000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s41999-020-00349-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,22]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["349"],"URL":"https:\/\/doi.org\/10.1007\/s41999-020-00349-4","relation":{},"ISSN":["1878-7657"],"issn-type":[{"type":"electronic","value":"1878-7657"}],"subject":[],"published":{"date-parts":[[2020,6,22]]},"assertion":[{"value":"31 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors have declared no conflicts of interest for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Auburn University Institutional Review Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent is not required for this type of study according to the US federal government regulations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}